BCSC Blog

The BCSC blog was founded in late 2018 and features contributions from a variety of BCSC investigators, sharing their current work and highlighting the the impact of the BCSC. 

Current Blog Posts:

Despite a strong overall rebound in mammography volume, a substantial cumulative deficit in missed mammograms remains
New study suggests screening women ages 50-74 with lower than average risk and low breast density every three years
New study finds risk-based approach detects most cancers with fewest exams
BCSC study suggests disparities in access to and use of newer screening technology based on race/ethnicity and socioeconomic status
Editorial describes how combining risk factors with breast density to determine age and frequency of breast cancer screening maximizes benefits and minimizes harms
BCSC is exploring the effect of reduced breast cancer screening during COVID-19 on patient outcomes
BCSC study determines advanced cancer definition that accurately predicts breast cancer mortality, which is useful for evaluating screening effectiveness.
Among women with a family history of breast cancer, the relative’s age at diagnosis may influence her age at first mammogram.
BCSC will leverage its data and relationships with breast imaging facilities nationwide to develop a prioritization toolkit to help facilities deal with closures and reduced capacity during the COVID-19 pandemic.
New findings from the BCSC suggest that overweight/obesity and dense breasts account for large proportions of breast cancers in white, black, Hispanic, and Asian women.
New BCSC study suggests that the benefits of digital breast tomosynthesis (DBT) depend on a woman's age, breast density, and screening round.
Interview with BCSC researcher Karen Schifferdecker, PhD, MPH, in July 2020 issue of HealthCareBusiness news for their special "Women's Health Imaging Section."
BCSC investigators develop metrics that consider the result of the entire mammography screening episode, not just the initial assessment.
New findings recognize that social determinants of health (SDOH) contribute to health-related disparities.
BCSC investigator, Dr. Diana Miglioretti, PhD, was awarded the Distinguished Investigator Award from the Association of Clinical and Translational Science (ACTS).
New BCSC findings suggest that using DBT leads to a higher cancer detection rate and lower recall rate compared to digital mammography.
New qualitative findings from the BCSC suggest that women have varying knowledge about breast density and a strong desire to learn more.
BCSC investigator, Dr. Christoph Lee, at the University of Washington establishes a new breast cancer screening registry in the Pacific Northwest
BCSC investigators, in collaboration with the CISNET and PROSPR groups, use similation modeling to understand the cost-effectiveness and long-term outcomes for women screened with digital breast tomosythesis.
BCSC investigators explore the benefits of screening mammography in women age 75 and older
BCSC investigators explore strategies for identifying women with the most potential benefit from supplemental imaging during the screening process
BCSC investigators and patient partners evaluate the performance of Breat MRI in women with a history of breast cancer
BCSC investigators Drs. Kerlikowske, Miglioretti and Vachon, discuss breast density, its measurement, and its impact on breast cancer risk
BCSC investigator Dr. Diana Miglioretti presented a keynote address highlighting the potential benefit of risk-stratified screening
BCSC study finds little benefit from adding ultrasound to screening mammography
BCSC study finds radiologists quickly improve screening performance with 3D mammography
Analyses suggest association between environmental exposures and breast density.
Changes to BI-RADS Density Guidelines seem unlikely to impact population distributions of breast density.
Updated USPSTF Recommendations suggest BCSC Risk Calculator to identify women who might benefit from medication to reduce breast cancer risk
Study suggest BPE is an independent risk factor for breast cancer.
More DBT doesn't mean fewer screening exams